Respiratory care is a healthcare specialty that focuses on improving cardiopulmonary function and promoting health and wellness. Respiratory care devices are majorly categorized into therapeutic, diagnostic, & monitoring devices; and consumables & accessories. These devices are majorly used to in the treatment of medical conditions such as asthma, COPD, and other acute & chronic respiratory diseases. Respiratory care devices are used in hospital and homecare settings. The respiratory care devices market has experienced a paradigm shift from stationary to portable devices. Increased adoption of portable devices is a significant trend in the industry.
The global market is driven by factors such as increase in prevalence rate of respiratory diseases, rapid urbanization, increase in pollution level, growth in geriatric population, and increase in tobacco consumption worldwide. In addition, factors such as proactive governmental support have fueled the market growth. Moreover, high demand for therapeutic devices in homecare settings and increased healthcare spending are expected to provide lucrative opportunities for market players. However, large pool of undiagnosed population and risks associated with certain therapeutic devices for neonates hamper the growth of the respiratory care devices market.
The report segments the global respiratory care devices market on the basis of product, end user, and geography. Based on the type of product, the market is categorized into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. Therapeutic respiratory care devices are subsegmented into positive airway pressure (PAP) devices, which include continuous positive airway pressure (CPAP) devices, automatic positive airway pressure (APAP) devices, and bi-level positive airway pressure (BPAP) devices; masks, which include nasal mask, full-face mask, nasal pillow mask, and oral masks; ventilators; nebulizers; humidifiers; oxygen concentrators, which include fixed and portable oxygen concentrators; inhalers, which comprise dry powder inhalers and metered dose inhalers; reusable resuscitators, which include adult and neonatal resuscitators; nitric oxides delivery units; capnographs, gas analyzers, and oxygen hoods. Respiratory care monitoring devices include pulse oximeters, which is further segmented into pediatric pulse oximeters, wrist-worn pulse oximeters, handheld oximeter, fingertip pulse oximeter, and table-top/bedside pulse oximeters. The diagnostic respiratory care devices market is segmented into spirometers, polysomnography (PSG) devices, and peak flow meters. The respiratory care consumables and accessories devices market is categorized into disposable resuscitators, tracheostomy tubes, nasal cannulas, disposable masks, and other consumables & accessories. The end users of the industry are homecare settings and hospitals. The global market is segmented based on four regions, which include North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By End User
Other players operating in the industry (profiles not included in the report)
The Global Pulmonary Function Testing Systems market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Pulmonary Function Testing Systems market, especially in North America, Europe, ...
December 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Pulmonary Function Testing Systems market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Pulmonary Function Testing Systems in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, ...
December 2017 | $4660 |View Details>>
In 2016, the Pulmonary Function Testing Systems market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include CareFusion(BD) Schiller ...
December 2017 | $3360 |View Details>>
In 2016, the Europe Pulmonary Function Testing Systems market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Pulmonary Function Testing Systems in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey ...
December 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research